Form 4: Molina Healthcare Director Dale B. Wolf Acquires Additional Shares Under Equity Incentive Plan
SEC Form 4 Filing
Director Dale B. Wolf acquired 136 shares of Molina Healthcare common stock on April 1, 2024, as part of the company's 2019 Equity Incentive Plan.
Summary
- On April 1, 2024, Dale B. Wolf, a director of Molina Healthcare, Inc., acquired 136 shares of common stock.
- The acquisition was part of the company's 2019 Equity Incentive Plan and is related to Wolf's service as a director.
- The shares were granted at a price of $404.20 per share, reflecting the closing price of Molina Healthcare's common stock on that day.
- Following the transaction, Wolf directly owns 15,003 shares of Molina Healthcare common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and ongoing governance structure. The sentiment is neutral to slightly positive as it reflects standard operating procedure.
Positives
- The equity grant aligns director compensation with company performance.
- The director's continued stock ownership demonstrates confidence in the company's future.
Industry Context
Equity grants to directors are a common practice in publicly traded companies to align their interests with those of shareholders. The size and frequency of these grants can vary depending on company size, industry, and compensation philosophy.
Comparison to Industry Standards
- Director compensation packages, including equity grants, vary widely across the healthcare industry.
- Companies like UnitedHealth Group, Anthem (now Elevance Health), and Cigna also utilize equity-based compensation for their directors.
- The $220,000 annual equity award for Molina Healthcare directors is within the typical range for companies of similar size and market capitalization, but a detailed comparison would require analyzing the full compensation packages of directors at peer companies.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders by aligning director interests with company performance.
- The equity grant serves as part of the compensation package for the director.
Key Dates
| Date | Description |
|---|---|
| March 11, 2013 | Date of Limited Power of Attorney for Section 16(a) Filings |
| April 01, 2024 | Date of stock acquisition |
| April 02, 2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.